Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (1058) Astepro (azelastine hydrochloride nasal spray), Meda Pharmaceuticals,
...reported adverse reactions with Astepro Nasal Spray 0.15% were bitter taste, headache, sinusitis, and epistaxis. Focused nasal examinations were performed and no nasal ulcerations or septal perforations were observed. There were no reports of severe epistaxis. Side Effects Adverse events associated with the use of Astepro Nasal Spray may include, but ...
View Page

2.  Newly Approved Drug Therapies (49) Atrovent (ipratropium bromide), Boehringer Ingelheim,
...and has been shown to have minimal side effects such as transient nasal dryness and epistaxis (nasal bleeding) in less than 10% of patients. Mechanism of Action There are many factors ...
View Page

3.  Newly Approved Drug Therapies (982) Patanase (olopatadine hydrochloride), Alcon,
...the long term safety of this product with respect to local nasal adverse effects, including epistaxis and nasal ulceration, as well as systemic effects. Include at least the following three treatment ...
...use of Patanase may include, but are not limited to, the following: • Bitter taste • Headache • Epistaxis • Pharyngolaryngeal Pain • Post-nasal drip • Cough • Urinary tract infection Mechanism of Action Patanase is an ...
View Page

4.  Newly Approved Drug Therapies (949) Veramyst (fluticasone furoate), GlaxoSmithKline,
...in adult and adolescent patients may include, but are not limited to, the following: • Headache • Epistaxis • Pharynolaryngeal pain • Nasal ulceration • Back pain Adverse events associated with the use of Veramyst in pediatric patients may include, but are not limited to, the following: • Headache • Nasopharyngitis • Epistaxis • Pyrexia • Pharynolaryngeal pain • Cough In addition, Veramyst may result in the development of glaucoma and ...
View Page

5.  Newly Approved Drug Therapies (1039) Avastin (bevacizumab), Genentech,
...associated with the use of Avastin may include, but are not limited to, the following: • epistaxis • headache • hypertension • rhinitis • proteinuria • taste alteration • dry skin • rectal hemorrhage • lacrimation disorder • back pain • exfoliative ...
View Page

6.  Newly Approved Drug Therapies (988) Aptivus (tipranavir), Boehringer Ingelheim,
...may include, but are not limited to, the following: • Pyrexia • Vomiting • Cough • Rash • Nausea • Diarrhea • Epistaxis Mechanism of Action Tipranavir is an HIV-1 protease inhibitor that inhibits the virus-specific ...
View Page

7. Clinical Trial Results by Drug Names
...associated with Avastin therapy (adverse events of special interest) the most common were thrombocytopenia, neutropenia, epistaxis and hypertension. NCI-CTCAE grade 3-5 AEs of special interest were mainly hematological such ...
View Page

8. Clinical Trial Results by Drug Names
...Avastin arms was mostly driven by hypertension (all Grades) and certain bleeding events (e.g. epistaxis). Overall, Avastin did not seem to increase the known toxicities of cisplatin/gemcitabine and no ...
View Page

9. Clinical Trial Results by Drug Names
...decreased (44.2%), whereas the most commonly reported Avastin-related AEs were hypertension (22.9%), epistaxis (17.8%), fatigue (14.7%) and proteinuria (9.4%). There were a total of 1133 ...
View Page

10. Clinical Trial Results by Drug Names
...an incidence of more than 20%, were fatigue (57%), alopecia (46%), neutropenia (42%), anorexia (40%), epistaxis (38%), mucosal inflammation (37%), headache and hypertension (each 26%), insomnia (22%) and dyspnea (21%). For ...
View Page

11.  Newly Approved Drug Therapies (952) Xyzal (levocetirizine dihydrochloride), UCB,
...to 12 years may include, but are not limited to, the following: • Pyrexia • Cough • Somnolence • Epistaxis Mechanism of Action The active component of Xyzal, Levocetirizine dihydrochloride, is the R enantiomer of ...
View Page

12. Clinical Trial Results by Drug Names
...throughout most or all of the study. One of these patients reported an AE of epistaxis (severe, possibly related). Chemistry Laboratory Tests. Mean baseline values of ALT, aspartate aminotransferase (AST) alkaline ...
View Page

13. Clinical Trial Results by Drug Names
...xerosis, application site pain, injection site bruising, injection site pain, reversible posterior leukoencephalopathy syndrome and epistaxis). The reversible posterior leukoencephalopathy syndrome, which occurred during the core study period, was a serious ...
View Page